JNCCN 360 - NSCLC - Available Clinical Trials

Editor:

David S. Ettinger, MD, FACP, FCCP

Advertisement

Advertisement

Available Clinical Trials

A Randomized Phase II Trial of Adjuvant Pembrolizumab for Stage I Non-Small Cell Lung Cancer with Primary Tumors Between 1-4 cm

City of Hope Comprehensive Cancer Center

Cleveland Clinic Taussig Cancer Institute

Fox Chase Cancer Center

Fred and Pamela Buffett Cancer Center

Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance

Huntsman Cancer Institute at the University of Utah

Mayo Clinic Cancer Center

Memorial Sloan Kettering Cancer Center

Moffitt Cancer Center

Phase II Study of Adjuvant Treatment with Cisplatin-Based Chemotherapy Plus Concomitant Atezolizumab in Patients With Non-Small Cell Lung Cancer

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Roswell Park Cancer Institute

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center, NORTHSTAR Trial

UC San Diego Moores Cancer Center

UCSF Helen Diller Family Comprehensive Cancer Center

University Hospitals Seidman Cancer Center

University of Colorado Cancer Center

University of Michigan Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center

Vanderbilt-Ingram Cancer Center, Afatinib and Necitumumab

Yale Cancer Center / Smilow Cancer Hospital

Sections

NCCN Resources

Copyright © 2022 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.